197 related articles for article (PubMed ID: 4083215)
1. [Staging pelvic lymphadenectomy for carcinoma of the prostate].
Rinsho K; Ishikawa S; Nemoto R; Koiso K; Takeshima H; Uchida K
Hinyokika Kiyo; 1985 Sep; 31(9):1583-7. PubMed ID: 4083215
[TBL] [Abstract][Full Text] [Related]
2. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
Heidenreich A; Varga Z; Von Knobloch R
J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
[TBL] [Abstract][Full Text] [Related]
3. [Staging pelvic lymphadenectomy for the prostatic cancer].
Fuse H; Zama S; Akimoto S; Shimazaki J; Matsuzaki O; Murakami S; Igarashi T
Hinyokika Kiyo; 1986 Oct; 32(10):1465-70. PubMed ID: 3565182
[TBL] [Abstract][Full Text] [Related]
4. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE.
Kawakami J; Meng MV; Sadetsky N; Latini DM; Duchane J; Carroll PR;
J Urol; 2006 Oct; 176(4 Pt 1):1382-6. PubMed ID: 16952638
[TBL] [Abstract][Full Text] [Related]
5. [Clinical outcome of radical prostatectomy and pelvic lymph node dissection].
Mizutani K; Ono Y; Kato N; Takeda A; Yamada S; Kinukawa T; Hattori R; Sahashi M; Matsuura O; Takeuchi N
Hinyokika Kiyo; 1995 Nov; 41(11):867-71. PubMed ID: 8533688
[TBL] [Abstract][Full Text] [Related]
6. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
Cagiannos I; Karakiewicz P; Eastham JA; Ohori M; Rabbani F; Gerigk C; Reuter V; Graefen M; Hammerer PG; Erbersdobler A; Huland H; Kupelian P; Klein E; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Morash CG; Scardino PT; Kattan MW
J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
[TBL] [Abstract][Full Text] [Related]
7. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
Heidenreich A; Ohlmann CH
Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
[TBL] [Abstract][Full Text] [Related]
8. Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma.
Elfving P; Lundgren R
Scand J Urol Nephrol Suppl; 1988; 110():155-61. PubMed ID: 3142034
[TBL] [Abstract][Full Text] [Related]
9. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
[TBL] [Abstract][Full Text] [Related]
11. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis of the patients with prostate cancer clinically confined within the pelvis].
Akimoto S; Masai M; Isaka S; Shimazaki J; Murakami S; Igarashi T
Hinyokika Kiyo; 1990 Sep; 36(9):1039-45. PubMed ID: 2239609
[TBL] [Abstract][Full Text] [Related]
13. [Staging pelvic lymphadenectomy for carcinoma of the prostate: review of 23 cases].
Arai Y; Taniguchi T; Kaku S; Kihara Y; Okada K; Kawamura J
Hinyokika Kiyo; 1986 Mar; 32(3):401-6. PubMed ID: 3728242
[TBL] [Abstract][Full Text] [Related]
14. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
[TBL] [Abstract][Full Text] [Related]
15. Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy.
Heidenreich A; Pfister D; Thüer D; Brehmer B
BJU Int; 2011 Jan; 107(2):220-5. PubMed ID: 20590538
[TBL] [Abstract][Full Text] [Related]
16. Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?
Miyake H; Sakai I; Harada K; Hara I; Eto H
Int J Urol; 2005 Aug; 12(8):739-44. PubMed ID: 16174048
[TBL] [Abstract][Full Text] [Related]
17. [Gleason's system and pelvic lymphadenectomy in the pretherapeutic evaluation of cancer of the prostate. Apropos of 85 cases].
Luciani L; Coccarelli F; Pusiol T; Piscioli F
J Urol (Paris); 1988; 94(2):87-9. PubMed ID: 3392408
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
Weckermann D; Dorn R; Trefz M; Wagner T; Wawroschek F; Harzmann R
J Urol; 2007 Mar; 177(3):916-20. PubMed ID: 17296375
[TBL] [Abstract][Full Text] [Related]
19. [Laparoscopic pelvic lymphadenectomy for localized prostate cancer].
Hattori R; Kinukawa T; Ono Y; Kato N; Yamada S; Takeda A; Fujita T; Nishiyama N; Oshima S; Matsuura O; Takeuchi N
Hinyokika Kiyo; 1996 Oct; 42(10):775-80. PubMed ID: 8951474
[TBL] [Abstract][Full Text] [Related]
20. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
Bader P; Burkhard FC; Markwalder R; Studer UE
J Urol; 2003 Mar; 169(3):849-54. PubMed ID: 12576797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
